SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-18-220931
Filing Date
2018-07-19
Accepted
2018-07-19 06:10:41
Documents
6

Document Format Files

Seq Description Document Type Size
1 F-3 d875040df3.htm F-3 310196
2 EX-5.1 d875040dex51.htm EX-5.1 17002
3 EX-23.2 d875040dex232.htm EX-23.2 1775
4 GRAPHIC g875040dsp03.jpg GRAPHIC 4801
5 GRAPHIC g875040g0716082134208.jpg GRAPHIC 4104
6 GRAPHIC g875040g0716083733452.jpg GRAPHIC 2802
  Complete submission text file 0001193125-18-220931.txt   346598
Mailing Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077
Business Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: F-3 | Act: 33 | File No.: 333-226240 | Film No.: 18959496
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1